منابع مشابه
Routine vaccination against MenB
Effective polysaccharide(conjugate) vaccines against Neisseria meningitidis serogroups A, C, W, and Y have been widely used, but serogroup B meningococci remain a major cause of severe invasive meningococcal disease (IMD) worldwide, especially in infants. Recently, a vaccine, 4CMenB (Bexsero(®)), containing three recombinant proteins, and outer membrane vesicles (OMV) derived from a serogroup B...
متن کاملPopulation-wide benefits of routine vaccination of children against influenza.
Using a stochastic simulation model of influenza transmission, clinical illness, and economic costs, we estimated the population-wide benefits of routinely vaccinating US children (ages 6 months to 18 years) against influenza. Disease burden was projected to decline as a result of both reduced susceptibility to infection among vaccinees and reductions in disease transmission to others in the co...
متن کاملProspects for routine childhood vaccination against rotavirus in India.
Rotavirus is the leading cause of severe acute gastroenteritis (AGE) in children under 5 years of age worldwide. In both developing and industrialized countries, about one-third of AGE hospitalizations in children under 5 are attributable to rotavirus infection. While rotavirus AGE is ubiquitous, more than 90% of the estimated 453 000 annual rotavirus deaths occur in developing countries, prima...
متن کاملGlobal Routine Vaccination Coverage, 2013
In 1974, the World Health Organization (WHO) established the Expanded Program on Immunization to ensure that all children have access to routinely recommended vaccines. Since then, global coverage with the four core vaccines (Bacille Calmette-Guérin vaccine [for protection against tuberculosis], diphtheria-tetanus-pertussis vaccine [DTP], polio vaccine, and measles vaccine) has increased from <...
متن کاملExploring the population-level impact of MenB vaccination via modeling: Potential for serogroup replacement
Various meningococcal conjugate vaccines exist against serogroups A, C, W and Y. A new protein-based vaccine targeting serogroup B (MenB) is also now available. The potential of such vaccines to drive serogroup replacement is considered a possible public health concern when implementing nationwide routine immunization programmes. The aim of this work was to investigate if and how serogroup repl...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Human Vaccines & Immunotherapeutics
سال: 2013
ISSN: 2164-5515,2164-554X
DOI: 10.4161/hv.26816